The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Bramah N. Singh

Division of Cardiology

Veterans Administration Greater Los Angeles Healthcare System

Los Angeles

USA

[email]@ucla.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Cardiology, Veterans Administration Greater Los Angeles Healthcare System, Los Angeles, USA. 2010
  • David Geffen School of Medicine at UCLA, VA Greater Los Angeles Health Care System, 11301 Wilshire Boulevard, Los Angeles, USA. 2006 - 2009
  • Cardiology Division, Veterans Affairs Greater Los Angeles Healthcare System and the David Geffen School of Medicine at UCLA, Los Angeles, CA 90073, USA. 2004 - 2007
  • Division of Cardiology, VAMC of West Los Angeles, Department of Medicine, UCLA School of Medicine, USA. 1999 - 2005
  • Department of Veterans Affairs Medical Center, West Los Angeles, Calif 90073, USA. 2005
  • VA Greater Los Angeles, Health Care System and the UCLA School of Medicine, Los Angeles, California, USA. 2002
  • Cardiology Section (111E), UCLA School of Medicine, USA. 2000

References

  1. Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations. Singh, B.N. J. Cardiovasc. Pharmacol. Ther. (2010) [Pubmed]
  2. A new agent for atrial fibrillation: electrophysiological properties of dronedarone. Singh, B.N., Cingolani, E. J. Cardiovasc. Pharmacol. Ther. (2010) [Pubmed]
  3. Atrial fibrillation: from ion channels to bedside treatment options. Singh, B. J. Electrocardiol (2009) [Pubmed]
  4. Amiodarone as paradigm for developing new drugs for atrial fibrillation. Singh, B.N. J. Cardiovasc. Pharmacol. (2008) [Pubmed]
  5. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. Singh, B.N., Connolly, S.J., Crijns, H.J., Roy, D., Kowey, P.R., Capucci, A., Radzik, D., Aliot, E.M., Hohnloser, S.H. N. Engl. J. Med. (2007) [Pubmed]
  6. Amiodarone: a multifaceted antiarrhythmic drug. Singh, B.N. Curr. Cardiol. Rep (2006) [Pubmed]
  7. Amiodarone versus sotalol for atrial fibrillation. Singh, B.N., Singh, S.N., Reda, D.J., Tang, X.C., Lopez, B., Harris, C.L., Fletcher, R.D., Sharma, S.C., Atwood, J.E., Jacobson, A.K., Lewis, H.D., Raisch, D.W., Ezekowitz, M.D. N. Engl. J. Med. (2005) [Pubmed]
  8. Beta-Adrenergic blockers as antiarrhythmic and antifibrillatory compounds: an overview. Singh, B.N. J. Cardiovasc. Pharmacol. Ther. (2005) [Pubmed]
  9. Antiarrhythmic and proarrhythmic properties of QT-prolonging antianginal drugs. Singh, B.N., Wadhani, N. J. Cardiovasc. Pharmacol. Ther. (2004) [Pubmed]
  10. Atrial fibrillation: epidemiologic considerations and rationale for conversion and maintenance of sinus rhythm. Singh, B.N. J. Cardiovasc. Pharmacol. Ther. (2003) [Pubmed]
  11. Significance and control of cardiac arrhythmias in patients with congestive cardiac failure. Singh, B.N. Heart. Fail. Rev (2002) [Pubmed]
  12. What niche will newer class III antiarrhythmic drugs occupy?. Singh, B.N., Sarma, J.S. Curr. Cardiol. Rep (2001) [Pubmed]
  13. A fourth class of anti-dysrhythmic action? Effect of verapamil and ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function. Singh, B. Cardiovasc. Res. (2000) [Pubmed]
  14. The relevance of sympathetic activity in the pharmacological treatment of chronic stable angina. Singh, B.N. Can. J. Cardiol (1999) [Pubmed]
 
WikiGenes - Universities